Food Allergy Treatment Market Size, Share, By Food Source (Peanut Allergies, Tree Nut Allergies, Dairy Product Allergies, and Others), By Allergic Reaction (Immunoglobulin E (IgE) Mediated, and Non-IgE Mediated), By Diagnosis Tests (Skin Prick Test(SPT), Blood Test, Oral Food Challenge (OFC) and Others), By Treatment Type (Antihistamines, Oral Immunotherapy (OIT), Epinephrine Auto-Injectors (EpiPens), Other Treatments), By End-Use (Hospitals and Clinics, Ambulatory Care Settings, Home Care), and By Region - Trends, Analysis, and Forecast till 2034

Food Allergy Treatment Market Size was valued at USD 6.15 Billion in 2024 and is expected to reach USD 13.4 Billion by 2034 growing at a CAGR of 8.9%

Food allergies are adverse reactions caused by the body's immune response to specific foods. A person with food allergies may display a range of symptoms after eating a food containing an allergen. The eight most common food allergies are peanuts, tree nuts, milk, eggs, fish, shellfish, soy, and wheat. Symptoms can include hives, swelling, gastrointestinal symptoms, respiratory distress, and, in severe cases, anaphylaxis. Generally, diagnosis is by medical history, skin prick tests, and blood tests. The mainstay of treatment is strict avoidance of allergenic foods and the availability of emergency medications, such as epinephrine auto-injectors.

A worldwide and currently increasing prevalence is reported, especially in pediatric patients. The search for therapy intervention is ongoing, among which are oral immunotherapy and early introduction strategies. This has achieved overdue recognition and is currently stirring up a high-tides-will-raise-all-boats dynamic and swelling in the food allergy treatment market. The market possesses the opportunity to address the increasing demand for correct diagnosis and safe treatment to enter a future without the fear of allergic reactions eventually.

The key management for food allergy is strict avoidance of the offending food and education regarding managing accidental exposures. It is most useful in managing accidental ingestions causing mild reactions; in severe cases, such as anaphylaxis, epinephrine should be given promptly. Newer treatments to have been developed to mitigate the intensity of the reaction are under research. Immunotherapy approaches under study (e.g., OIT and EPIT) gradually expose patients to larger quantities of allergen to build tolerance, though treatments with these regimens are not generally recommended. The patient should have an action plan, be able to take emergency medications, and have regular reviews by an allergist to help and effectively manage the condition.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Key Drivers of Target Market:

Increasing Prevalence of Food Allergies

• One of the prominent factors driving this market is the rising prevalence of food allergies across the globe. Statistics represent a phenomenal increase in the number of food allergy cases, particularly in children. This increase in allergies stimulates demand for precise diagnosis, effective modes of treatment, and prophylactic measures.

Improved Diagnostics and Increasing Awareness:

• This would result in better chances for early detection and better ways to manage a certain food allergy through better diagnostic tools like skin prick tests, blood tests, and oral food challenges.

Restrains:

Unavailability of Specialized Treatments:

• Although novel treatments such as OIT have already shown promise with current development, some are not being offered in many places. Possible reasons include not enough specialists trained to perform these treatments and the need for them to be given in a tightly controlled medical setting.

Opportunities:

Early detection and diagnosis:

• Low-cost, highly accurate, non-invasive diagnostic tests could be developed to detect early childhood food allergies. This could be in terms of developing more sensitive and specific blood tests for a broader range of food allergies. Also, coming up with home testing kits that are user-friendly and result-oriented would help so much. The earlier a diagnosis is determined, the earlier one may start management strategies, preventing accidental exposures that may lead to severe reactions. Ideally, The tests should be painless, requiring the least sample and giving the status within a short duration, such as that of a finger prick rather than a blood draw. Such an opportunity would allow for early intervention and possibly better the long-term prognosis of food allergy sufferers.

The market is segmented based on Food Source, Allergic Reaction, End-User, and Region.

Food Source Insights:

• Peanut Allergies: This is the largest segment because of how common and serious peanut allergy reactions can be. Peanut allergies are the most common of all food allergies and have reached into the millions for both children and adults. Reactions can vary from mild skin irritation to anaphylaxis, which can be fatal. Due to its severity and unanticipated reactions, this is an important area that has captured interest in the treatment of peanut allergy.
• Tree Nut Allergies: Tree nut allergies have become one of the fastest-growing allergies claimed by individuals. Several factors likely contribute to the increase in the number of tree nut allergies. This could be due to better-identifying tools or to better awareness of nut allergies among parents and caregivers. As a result, a greater range of tree nut allergens has been introduced to the marketplace for treatments for those who suffer from tree nut allergies.
• Dairy Product Allergies: Since most common in children, this segment will be the prime driver of the market for alternative milk products (soy milk, almond milk, rice milk, oat milk, etc.) and treatments developed for milk allergies, such as CMPA. The most common type of dairy allergy is cow's milk protein allergy, common in babies and young children. Symptoms manifest as diarrhea, vomiting, cramps, skin manifestations such as eczema, or respiratory problems if it causes wheezing issues. Luckily, most children tend to grow out of CMPA by 3-5.
• Others: This category includes shellfish, wheat, fish, sesame, and other foods that are allergens. As consumer awareness of food allergies increases, this category continues to rise. The market in this category can develop allergen-specific treatments, avoidance solutions, and alternate foodstuffs to address different dietary concerns.

Allergic Reaction Insights:

• Immunoglobulin E (IgE) Mediated: This represents the most widely occurring form of food allergy, which involves the immune system producing IgE antibodies in response to certain food proteins. Primary modes of treatment in this segment include antihistamines, epinephrine auto-injectors, and OIT.
• Non-IgE-Mediated: These are less commonly but still widespread immune system reactions that do not involve the activities of the IgE antibodies. Diagnosis and treatment options often become considerably more complex for this category, and they can include exclusion diets, food formulation diets, and proprietary specialty pharmaceutical treatments.

Diagnosis Test Insights:

• Skin Prick Test (SPT): Most common and less costly than others. SPT is much in practice when testing for allergies.
• Blood Test: It is convenient and noninvasive, though positive results require further tests for allergen confirmation.
• Oral Food Challenge (OFC): Gold standard test for diagnosis. However, it is limited since it risks dangerous reactions and can be performed under controlled medical environments.
• Others: This section contains some of the test types still emerging in diagnosing food allergy, for example, food-specific IgE tests and elimination/reintroduction diets.

Treatment Type Insights:

• Antihistamines: This is the largest category. It involves first- and second-generation drugs used to treat all but severe cases of allergies.
• Oral Immunotherapy (OIT): It is a new, developing category that holds great promise. This treatment desensitizes the immune response by gradually exposing the patient to the food that causes the allergies.
• Epinephrine Auto-injectors (EpiPens): A crucial emergency treatment for severe allergic reactions (anaphylaxis). They deliver a dose of epinephrine to counteract the reaction quickly.
• Other Treatments: This entails corticosteroids, leukotriene receptor antagonists, and advanced therapies such as biologics and enzyme replacement therapies for certain allergic reactions.

End-User Insights:

• Hospitals and Clinics: This represents the need for allergy treatment products and services seconded in healthcare facilities, e.g., specialist consultation, allergy tests, and emergency care.
• Ambulatory Care Settings: Physicians' offices and allergy specialists add to the market demand for initial diagnoses, allergy tests, and ongoing treatment plans.
• Home Care: This is the largest segment, including the market for self-administered medications such as antihistamines and EpiPens, allergen avoidance strategies, and home management tools.

Regional Insights

• North America: Currently leading the market for food allergies, since previous health care spending and incidence of food allergies are higher here; food allergies have also been identified more commonly than in other regions. Significant investment in research and development leads to advancements in diagnostics, medications, and innovative therapies like OIT.
• Asia Pacific: One of the emerging markets with an exceptionally rapidly increasing population and raising awareness concerning food allergies—high demand for allergy treatment that is affordable and accessible in this region.
• Europe is a large, mature market in which novel treatments for allergy mitigation, such as OIT, are increasing in both awareness and adoption; however, the market still maintains a high growth rate due to rising disposable income.
• Latin America: The market scenario revolving around Latin American food allergy treatment holds abundance in growing landscapes. The market is less mature than in North America and Europe; however, it is growing with increased awareness and the dire needs of the people. Significant government support in increased diagnostics for allergies will critically impact the market, with specialist training and awareness among the people.
• Middle East and Africa: The MEA region represents a nascent market for food allergy treatment but with enormous potential. There will be an intensified interest in emerging therapies, such as OIT, but at this moment, it is limited. The development of a cost-effective and regionally affordable desensitization program is crucial.

Food Allergy Treatment Market Report Scope:

Attribute	Details
Market Size 2024	USD 6.15 Billion
Projected Market Size 2034	USD 13.4 Billion
CAGR Growth Rate	8.9%
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Million & CAGR from 2024 to 2034
Market Segmentation	By Food Source - Distribution Generation, Demand Response, and Mixed Asset. By Allergic Reaction - Renewable Energy, Energy Storage, and Cogeneration. By Diagnosis Tests - Skin Prick Test (SPT), Blood Test, Oral Food Challenge (OFC) and Others By Treatment Type - Antihistamines, Oral Immunotherapy (OIT), Epinephrine Auto-injectors (EpiPens), Other Treatments By End-User - Utilities, Commercial, Industrial, and Residential.
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and analyzes the latest industry trends and opportunities in each sub-segments from 2024 to 2034. For the purpose of this study segmented the target market report based on Food Source, Allergic Reaction, End-User, and Region.

Segmentation:

By Food Source:

• Peanut Allergies
• Tree Nut Allergies
• Dairy Product Allergies
• Others

By Allergic Reaction:

• Immunoglobulin E (IgE) mediated
• Non-IgE mediated

By Diagnosis Tests:

• Skin Prick Test (SPT)
• Blood Test
• Oral Food Challenge (OFC)
• Others

By Treatment Type:

• Antihistamines
• Oral Immunotherapy (OIT)
• Epinephrine Auto-injectors (EpiPens)
• Other Treatments

By End-User:

• Hospitals and Clinics
• Ambulatory Care Settings
• Home Care

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the Food Allergy Treatment Market include Johnson & Johnson, Sanofi, Novartis Pharmaceuticals, Aimmune Therapeutics, DBV Technologies, Regeneron Pharmaceuticals, Thermo Fisher Scientific, ALK Abello, Mast Group, Food Allergy Research & Education (FARE), Asthma and Allergy Foundation of America (AAFA).

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

• In February 2024, The United States Food and Drug Administration approved Xolair (omalizumab) injection for immunoglobulin E-mediated food allergy in confident adults and children aged one year and up for the reduction of allergic reactions (Type I), including the risk of anaphylaxis, that may occur as a result of accidental exposure to one or more foods. Patients on Xolair must continue to avoid foods that they are allergic to. Xolair is meant for repeated usage to lessen the risk of allergic reactions; however, it is not licensed to treat allergic reactions, including anaphylaxis immediately.
• In February 2021, Nestlé acquired Aimmune Therapeutics. Nestlé Health Science has partnered with Aimmune to build a global leader in food allergy prevention and treatment. Aimmune's recently approved therapy, Palforzia, would add to Nestlé Health Science's portfolio as the first and only FDA-approved treatment to help lessen the frequency and severity of allergic responses to peanuts in children.

• Johnson & Johnson*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Sanofi
• Novartis Pharmaceuticals
• Aimmune Therapeutics
• DBV Technologies
• Regeneron Pharmaceuticals
• Thermo Fisher Scientific
• ALK Abello
• Mast Group
• Food Allergy Research & Education (FARE)
• Asthma and Allergy Foundation of America (AAFA)

“*” marked represents similar segmentation in other categories in the respective section.

Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

Market Preview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Food Source
  • Market Snippet, By Allergic Reaction
  • Market Snippet, By Diagnosis Test
  • Market Snippet, By Treatment Type
  • Market Snippet, By End-User
  • Market Snippet, By Region
• Opportunity Map Analysis

Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Market Trends
• Product Launch
• Merger and Acquisitions
• Impact Analysis
• PEST Analysis
• Porter’s Analysis

Market Segmentation, Food Source, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Soy Milk
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Coconut Milk
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Cashew Milk
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Others
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, Allergic Reaction, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Immunoglobulin E (IgE) mediated
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Non-IgE mediated
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, Diagnosis Tests, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Skin Prick Test (SPT)
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Blood Test
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Oral Food Challenge (OFC)
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Others
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, Treatment Type, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Antihistamines
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Oral Immunotherapy (OIT)
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Epinephrine Auto-injectors (EpiPens)
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Other Treatments
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, End-User, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Hospitals and Clinics
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Ambulatory Care Settings
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Home Care
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Regional Trends
• North America
  • Market Size and Forecast (USD Bn), By Food Source, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Allergic Reaction, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Diagnosis Tests, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Treatment Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • U.S
    • Canada
• Asia Pacific
  • Market Size and Forecast (USD Bn), By Food Source, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Allergic Reaction, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Diagnosis Tests, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Treatment Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • India
    • Japan
    • South Korea
    • China
    • Rest of Asia Pacific
• Europe
  • Market Size and Forecast (USD Bn), By Food Source, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Allergic Reaction, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Diagnosis Tests, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Treatment Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • UK
    • Germany
    • France
    • Russia
    • Italy
    • Rest of Europe
• Latin America
  • Market Size and Forecast (USD Bn), By Food Source, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Allergic Reaction, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Diagnosis Tests, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Treatment Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • Brazil
    • Mexico
    • Rest of Latin America
• Middle East and Africa
  • Market Size and Forecast (USD Bn), By Food Source, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Allergic Reaction, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Diagnosis Tests, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Treatment Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • GCC
    • Israel
    • South Africa
    • Rest of the Middle East and Africa

Competitive Landscape

• Heat Map Analysis
• Company Profiles

• Johnson & Johnson
• Sanofi
• Novartis Pharmaceuticals
• Aimmune Therapeutics
• DBV Technologies
• Regeneron Pharmaceuticals
• Thermo Fisher Scientific
• ALK Abello
• Mast Group
• Food Allergy Research & Education (FARE)
• Asthma and Allergy Foundation of America (AAFA)

The Last Word

• Future Impact
• About Us
• Contact